Compounds > 1,5-anhydroglucitol
Page last updated: 2024-08-24

1,5-anhydroglucitol and Arteriosclerosis, Coronary

1,5-anhydroglucitol has been researched along with Arteriosclerosis, Coronary in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's8 (61.54)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Chałubińska-Fendler, J; Migała, M; Zielińska, M1
Chen, W; Dong, J; Ji, F; Li, H; Mu, H; Wang, S; Wang, X; Yang, R; Yu, X; Zhang, W; Zhou, Q1
Dai, XX; Gao, MX; Shi, GL; Su, G; Yao, WF; Zhang, T; Zhuang, SW1
Daida, H; Dohi, T; Endo, H; Isoda, K; Iwata, H; Kato, Y; Miyauchi, K; Ogita, M; Okai, I; Okazaki, S; Shimada, K; Suwa, S; Takahashi, N; Wada, H1
Hara, H; Hiroi, Y; Ikeda, N2
Ako, J; Arao, K; Fujiwara, T; Funayama, H; Kakei, M; Katayama, T; Mitsuhashi, T; Momomura, S; Nakamura, T; Sakakura, K; Sugawara, Y; Tsukui, T; Wada, H; Yamada, H; Yoshida, M1
Bao, Y; Hao, Y; Hu, X; Jia, W; Lu, Z; Luo, Y; Ma, X; Zhou, J1
Amaya, N; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Tada, H; Uzui, H1
Hara, H; Hiroi, Y; Ikeda, N; Nakamura, M1
Aikawa, T; Al Shahi, H; Daida, H; Hiki, M; Isoda, K; Kadoguchi, T; Miyauchi, K; Miyazaki, T; Ogita, M; Okazaki, S; Ouchi, S; Sai, E; Shimada, K; Shiozawa, T; Takahashi, S; Tamura, H; Tsuboi, S; Yoshihara, T1
Abramczyk, M; Bobkiewicz-Kozlowska, T; Borowska, M; Dworacka, M; Dworacki, G; Winiarska, H1
Bobkiewicz-Kozłowska, T; Dworacka, M; Wegner, M; Winiarska, H1

Other Studies

13 other study(ies) available for 1,5-anhydroglucitol and Arteriosclerosis, Coronary

ArticleYear
1,5-Anhydroglucitol as a Marker of Acute Hyperglycemia in Cardiovascular Events.
    The review of diabetic studies : RDS, 2022, 06-30, Volume: 18, Issue:2

    Topics: Acute Coronary Syndrome; Biomarkers; Blood Glucose; Coronary Artery Disease; Deoxyglucose; Glycated Hemoglobin; Humans; Hyperglycemia

2022
Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Biomarkers; Blood Glucose; China; Coronary Angiography; Coronary Artery Disease; Deoxyglucose; Glycated Hemoglobin; Humans; Prevalence; Risk Factors

2022
Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome.
    Cardiovascular diabetology, 2020, 05-30, Volume: 19, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Coronary Vessels; Deoxyglucose; Diabetes Mellitus, Type 2; Dinoprost; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Rupture, Spontaneous; Ultrasonography, Interventional

2020
Impact of serum 1,5-anhydro-D-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study.
    Cardiovascular diabetology, 2019, 06-03, Volume: 18, Issue:1

    Topics: Biomarkers; Blood Glucose; Coronary Artery Disease; Coronary Vessels; Deoxyglucose; Down-Regulation; Female; Humans; Hyperglycemia; Male; Middle Aged; Plaque, Atherosclerotic; Postprandial Period; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Ultrasonography, Interventional; Vascular Calcification

2019
1,5-Anhydro-D-glucitol predicts coronary artery disease prevalence and complexity.
    Journal of cardiology, 2014, Volume: 64, Issue:4

    Topics: Aged; Biomarkers; Coronary Artery Disease; Deoxyglucose; Female; Glycated Hemoglobin; Humans; Male; Predictive Value of Tests; Regression Analysis; Sensitivity and Specificity

2014
Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk.
    Heart and vessels, 2015, Volume: 30, Issue:4

    Topics: Aged; Biomarkers; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; ROC Curve; Serum Albumin

2015
Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c.
    Cardiovascular diabetology, 2015, Feb-07, Volume: 14

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Deoxyglucose; Female; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Serum Albumin

2015
Ability of 1,5-Anhydro-d-glucitol Values to Predict Coronary Artery Disease in a Non-Diabetic Population.
    International heart journal, 2015, Volume: 56, Issue:6

    Topics: Aged; Biomarkers; Blood Glucose; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Deoxyglucose; Early Diagnosis; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Japan; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors

2015
Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease.
    International journal of cardiology, 2016, Oct-15, Volume: 221

    Topics: AC133 Antigen; Aged; Antigens, CD34; Cell Count; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Eicosapentaenoic Acid; Endothelium, Vascular; Female; Humans; Hyperglycemia; Male; Middle Aged; Neovascularization, Pathologic; Risk Factors; Stem Cells; Vascular Endothelial Growth Factor Receptor-2

2016
Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
    Atherosclerosis, 2016, Volume: 253

    Topics: Aged; Area Under Curve; Blood Glucose; Cerebrovascular Disorders; Colorimetry; Coronary Angiography; Coronary Artery Disease; Deoxyglucose; Female; Follow-Up Studies; Heart Diseases; Humans; Hyperglycemia; Kaplan-Meier Estimate; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models

2016
Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.
    Cardiovascular diabetology, 2016, 10-11, Volume: 15, Issue:1

    Topics: Aged; Biomarkers; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Deoxyglucose; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Percutaneous Coronary Intervention; Predictive Value of Tests; Retreatment; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2016
Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients.
    Circulation journal : official journal of the Japanese Circulation Society, 2007, Volume: 71, Issue:6

    Topics: Acute Disease; Aged; Antigens, CD; Blood Glucose; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Lipids; Lymphocyte Count; Male; Middle Aged; Risk Factors; Tunica Intima

2007
IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
    Cytokine, 2008, Volume: 42, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin-12; Lipoproteins, HDL; Male; Middle Aged; Multivariate Analysis; Proinsulin; Regression Analysis; Sulfonylurea Compounds

2008